| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000243637.1 |
Ponatinib |
Bladder urothelial carcinoma |
0.006258609 |
Resistant |
| ENSG00000243637.1 |
Ponatinib |
Breast invasive carcinoma |
0.008482589 |
Sensitive |
| ENSG00000243637.1 |
Ponatinib |
Brain lower grade glioma |
0.042152614 |
Sensitive |
